Teva Wraps Up $703M Sale of Global Women’s Health Biz to CVC Capital Post author:Sam Post published:January 31, 2018 Post category:BioPharma The portfolio includes Ovaleap, Zoely, Seasonique, Colpotrophine, Actonel and additional products. Source: BioSpace You Might Also Like Cytokinetics To Announce First Quarter Results On April 27, 2017 April 13, 2017 Teligent Announces FDA Approval Of Erythromycin Topical Gel USP, 2% July 20, 2017 Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017
Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017